PMC:7120874 / 5080-5786 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7120874","sourcedb":"PMC","sourceid":"7120874","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7120874","text":"44 Serum samples from 24 SARS patients for differential mapping of SARS associated biomarkers.\n45 Serial serum samples from four additional SARS patients with comprehensive clinical follow-up for longitudinal correlation with clinical manifestation.\n10 Sera from 10 apparently healthy individuals (from a familial cancer screening clinic) as normal controls.\n72 Sera from 51 patients suffering from other viral or bacterial infections (influenza A virus [n = 12], influenza B virus [n = 8], respiratory adenovirus [n = 12], respiratory syncytial virus [n = 10], hepatitis B virus [n = 10], Mycobacterium tuberculosis [n = 10], other bacteria [n = 10]) as control patients for comparison with SARS patients.","divisions":[{"label":"p","span":{"begin":0,"end":94}},{"label":"p","span":{"begin":95,"end":249}},{"label":"p","span":{"begin":250,"end":358}}],"tracks":[]}